Lisinopril indications
Pro Research Analysisby 
Searched over 200M research papers for "lisinopril indications"
Consensus Meter
Indications for Lisinopril: A Comprehensive Overview
Hypertension Management
Lisinopril is widely recognized for its efficacy in managing hypertension. As an angiotensin-converting enzyme (ACE) inhibitor, it works by reducing plasma angiotensin II and aldosterone levels, which in turn lowers blood pressure (BP) without significantly affecting heart rate or cardiovascular reflexes. Clinical studies have shown that lisinopril produces a smooth, gradual reduction in both systolic and diastolic BP, with effects lasting for at least 24 hours after a single dose. It is particularly effective when combined with hydrochlorothiazide (HCTZ), enhancing its antihypertensive effects without causing common side effects like hypokalemia or hyperglycemia.
Congestive Heart Failure (CHF)
Lisinopril is also indicated for the treatment of congestive heart failure (CHF). It has been shown to improve exercise tolerance, increase left ventricular ejection fraction (LVEF), and reduce clinical signs and symptoms of CHF. Studies comparing lisinopril with captopril, another ACE inhibitor, have found that both drugs are equally effective in improving NYHA class and exercise tolerance. However, lisinopril has the added benefit of being effective in patients with renal impairment, a condition where captopril is less effective . Additionally, lisinopril increases cardiac output and decreases pulmonary capillary wedge pressure and mean arterial pressure in CHF patients.
Acute Myocardial Infarction (AMI)
Lisinopril has demonstrated significant benefits in the early management of acute myocardial infarction (AMI). The GISSI-3 trial, which included over 19,000 patients, showed that lisinopril, when administered within 24 hours of symptom onset, significantly reduced overall mortality and severe ventricular dysfunction at 6 weeks . The trial also indicated that these benefits were particularly pronounced in high-risk populations such as the elderly and women. Lisinopril's ability to attenuate left ventricular dilatation and improve survival rates makes it a valuable addition to post-AMI treatment protocols.
Insulin Sensitivity in Hypertensive Patients
In elderly patients with mild hypertension, lisinopril has been shown to improve insulin sensitivity. A study involving a euglycemic glucose clamp technique found that lisinopril significantly improved whole-body glucose disposal and non-oxidative glucose metabolism compared to placebo. This makes lisinopril a beneficial option for hypertensive patients who are also managing insulin resistance or diabetes.
Pulmonary Hypertension and Lung Fibrosis
Lisinopril has shown promise in treating conditions beyond traditional cardiovascular indications. For instance, it has been found to attenuate acute hypoxic pulmonary vasoconstriction, suggesting a potential role in managing hypoxemic pulmonary hypertension. Additionally, lisinopril has demonstrated antifibrotic effects in animal models of paraquat-induced lung fibrosis, indicating its potential utility in treating pulmonary fibrosis.
Conclusion
Lisinopril is a versatile ACE inhibitor with a broad range of indications, including hypertension, congestive heart failure, acute myocardial infarction, and even conditions like insulin resistance and pulmonary hypertension. Its efficacy, safety profile, and additional benefits in improving insulin sensitivity and reducing pulmonary fibrosis make it a valuable medication in various clinical settings.
Sources and full results
Most relevant research papers on this topic